1.Kuwayama N,
et al:Present Status in the Treatment of Dural Arteriovenous Fistulas in Japan:Jpn J Neurosurg 20:12-19,
2011.
2.Halbach VV,
et al: Treatment of dural arteriovenous malformations involving the superior saggital sinus.
Am J Neuroradiol 9:337-343,
1988.
3.Shimizu S,
et al: Sinus thrombosis probably resulting from a dural arteriovenous fistula development in the superior saggital sinus: Acta Neurochir 145:719-721,
2003
4.Bavinzski G,
et al: Variant Arteriovenous Fistula of the Supeior Sagittal Sinus: Neurol Med Chir 39:362-366,
1999.
5.Hamada Y,
Goto K,
Inoue T,
et al.
Histopathologic aspects of dural arteriovenous fistulas in the transverse-sigmoid sinus region in nine patients.
Neurosurgery 1997;40:452–458
6.Nishijima M,
Takaku A.
Endo S,
et al.
Etiologic evaluation of dural arteriovenous malformations of the lateral and sigmoid sinuses based on histopathological examinations.
J Neurosurg 1992;76:600–606
7.Terada T,
Higashida RT,
Halbach VV,
et al.
Development of acquired arteriovenous fistulas in rats due to venous hypertension.
J Neurosurg 1994;80:884–889
8.Uranishi R,
Nakase H,
Sakaki T.
Expression of angiogenic growth factors in dural arteriovenous fistula.
J Neurosurg 1999;91:781–786
9.Lawton MT,
Jacobowitz R,
Spetzler RF.
Redefined role of angiogenesis in the pathogenesis of dural arteriovenous malformations.
J Neurosurg 1997;87:267–274
10.Mironov A.
Selective transvenous embolization of dural fistulas without occlusion of the dural sinus.
AJNR Am J Neuroradiol 1998; 19:389 –391
11.Ohtakara K,
Murao K,
Kawaguchi K,
et al.
Selective transvenous liquid embolization of a Type 1 dural arteriovenous fistula at the junction of the transverse and sigmoid sinuses.
Case report.
J Neurosurg.
2000 Jun;92(6):1045-9
12.Caragine LP,
Halbach VV,
Dowd CF,
et al.
Parallel venous channel as the recipient pouch in transverse/ sigmoid sinus dural fistulae.
Neurosurgery 2003;53:1261-1267
13.Piske LP,
Monteiro C,
Jacinto B.L.
et al.
Dural sinus compartment in dural arteriovenous shunts:A new angioarchitectural feature allowing superselective transvenous dural sinus occlusion treatment.